nad has been researched along with Deafness, Transitory in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Dong, H; Fang, J; Mao, S; Shi, H; Su, K; Wu, H; Xing, Y; Yu, D; Zhang, J | 1 |
| Gao, Y; He, F; He, W; Huang, X; Jian, B; Liang, Z; Min, X; Pang, J; Xiong, H; Yang, H; Ye, Y; Zhan, T; Zhang, W; Zheng, Y | 1 |
| Chen, J; Hou, S; Huang, Y; Jia, H; Liang, M; Sun, X; Yang, J; Yu, H; Zhang, F | 1 |
| Choe, SK; Kim, HJ; Kwak, TH; Kwon, KB; Lee, S; Lee, SB; Oh, GS; Park, R; Seo, KS; Shen, A; So, HS | 1 |
| Harrington, M | 1 |
| Cho, EY; Choe, SK; Khadka, D; Kim, HJ; Kwak, TH; Lee, SB; Oh, GS; Pandit, A; Park, R; Shen, A; Shim, H; So, HS; Song, J; Yang, SH | 1 |
| Cho, EY; Choe, SK; Khadka, D; Kim, HJ; Kwak, TH; Lee, S; Lee, SB; Oh, GS; Pandit, A; Park, R; Shen, A; Shim, H; So, HS; Yang, SH | 1 |
| Haigis, MC; Santos, D; van de Ven, RAH | 1 |
2 review(s) available for nad and Deafness, Transitory
| Article | Year |
|---|---|
Nicotinamide adenine dinucleotide: An essential factor in preserving hearing in cisplatin-induced ototoxicity.
Topics: Animals; Antineoplastic Agents; Cisplatin; DNA Damage; Hearing; Hearing Loss; Humans; Inflammation; Metabolic Networks and Pathways; Models, Biological; NAD; Reactive Oxygen Species | 2015 |
Mitochondrial Sirtuins and Molecular Mechanisms of Aging.
Topics: Aging; Animals; Hearing Loss; Humans; Mitochondria; NAD; Neurodegenerative Diseases; Protein Interaction Maps; Sirtuins; Stress, Physiological | 2017 |
6 other study(ies) available for nad and Deafness, Transitory
| Article | Year |
|---|---|
A reduced form of nicotinamide riboside protects the cochlea against aminoglycoside-induced ototoxicity by SIRT1 activation.
Topics: 14-3-3 Proteins; Aminoglycosides; Animals; Anti-Bacterial Agents; Cochlea; Hearing Loss; Kanamycin; Mice; NAD; Niacinamide; Ototoxicity; Pyridinium Compounds; Reactive Oxygen Species; Resveratrol; Sirtuin 1 | 2022 |
Modulation of NAD
Topics: Animals; Animals, Genetically Modified; Carboxy-Lyases; Cisplatin; Disease Models, Animal; Enzyme Activation; Enzyme Inhibitors; Hair Cells, Auditory; Hearing; Hearing Loss; Lateral Line System; Mice, Inbred C57BL; Mitochondria; NAD; Ototoxicity; Sirtuin 1; Zebrafish | 2021 |
Hearing Protection Outcomes of Analog Electrode Arrays Coated with Different Drug-Eluting Polymer Films Implanted into Guinea Pig Cochleae.
Topics: Animals; Cochlear Implants; Cytarabine; Dexamethasone; Electrodes, Implanted; Evoked Potentials, Auditory, Brain Stem; Female; Guinea Pigs; Hearing Loss; NAD; Polymers | 2021 |
Augmentation of NAD(+) by NQO1 attenuates cisplatin-mediated hearing impairment.
Topics: Animals; Antineoplastic Agents; Cisplatin; Hearing Loss; Male; Mice; Mice, Knockout; MicroRNAs; NAD; NAD(P)H Dehydrogenase (Quinone); Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Sirtuin 1; Tumor Suppressor Protein p53 | 2014 |
Reversing neurodegenerative hearing loss.
Topics: Animals; Disease Models, Animal; Hearing Loss; Humans; Mice; Mice, Knockout; NAD; Neurodegenerative Diseases; Niacinamide; Pyridinium Compounds; Sirtuin 3 | 2015 |
Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism.
Topics: Acetylation; Animals; Cisplatin; Cochlea; Cytoprotection; Disease Models, Animal; Hearing; Hearing Loss; Male; Mice, Inbred C57BL; Mice, Knockout; MicroRNAs; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthoquinones; Poly (ADP-Ribose) Polymerase-1; Protective Agents; Signal Transduction; Sirtuin 1; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53 | 2016 |